The decision indefinitely blocks an appeals court ruling that would have restricted availability of the drug, especially in states with strict anti-abortion laws.
May 14, 2026
By Lawrence Hurley
WASHINGTON — The Supreme Court ensured Thursday that the abortion pill mifepristone can continue to be available by mail without an in-person appointment with a clinician.
A ruling by the New Orleans-based 5th U.S. Circuit Court of Appeals on May 1 had imperiled widespread access to the pill. Now, the Supreme Court has granted emergency requests brought by drugmakers Danco Laboratories and GenBioPro seeking to block that ruling.